Insulet Corp at Nasdaq Investor Conference Transcript
Amazing. Perfect. Well, hopefully, everyone can hear me. Welcome. This is Patrick Wood. I run the U.S. med tech team. I'm thrilled to have Lauren Budden here, who's the CFO of Insulet; and Deb Gordon, who runs IR and Communications, what should be, I think, a fun back and forth, talking about an exciting time for the company. And so I think why don't we just hop straight into Q&A, if that works?
Sure.
Questions & Answers
Amazing. Maybe if we start -- and unsure how familiar some of the audience are with some of the topics, it might be worth going over them. But O5, Omnipod 5, big, new product for you guys, great adoption in Q3. How are you thinking about the success of that platform and the movement into 2024?
Yes. So thanks, Patrick. Omnipod 5, we've been
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
